How big is the Optical Imaging Market?

The Optical Imaging Market size is expected to reach USD 2.60 billion in 2024 and grow at a CAGR of 11.30% to reach USD 4.45 billion by 2029. Read More

What is the current Optical Imaging Market size?

In 2024, the Optical Imaging Market size is expected to reach USD 2.60 billion. Read More

Which is the fastest growing region in Optical Imaging Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Optical Imaging Market?

In 2024, the Asia Pacific accounts for the largest market share in Optical Imaging Market. Read More

What years does this Optical Imaging Market cover, and what was the market size in 2023?

In 2023, the Optical Imaging Market size was estimated at USD 2.31 billion. The report covers the Optical Imaging Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Optical Imaging Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Optical Imaging Market Share

Statistics for the 2023 & 2024 Optical Imaging market share, created by Mordor Intelligence™ Industry Reports. Optical Imaging share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Optical Imaging Industry

The optical imaging market is highly fragmented, with the presence of major players like Carl Zeiss AG, Leica Microsystems (Danaher Corporation), Topcon Corporation, Canon Medical Systems Corporation (Canon Inc.), and Koninklijke Philips NV (Philips). Players in the market are adopting strategies such as partnerships and acquisitions to enhance their product offerings and gain sustainable competitive advantage.

October 2023 - Leica Microsystems ("Leica") announced the official opening of its USD 60 million medical manufacturing and R&D facility in Singapore. As one of Leica's four global production sites, Singapore is solely responsible for manufacturing surgical microscopes for export to global markets.
August 2023 - Abbott announced its ILUMIEN IV OPTIMAL PCI (ILUMIEN IV) clinical study, which demonstrated that intravascular imaging through optical coherence tomography (OCT) can enhance stent procedural outcomes, especially in complex cases. The study demonstrated that OCT guidance resulted in a statistically significant 7% rise in MSA compared to angiography guidance alone.